These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7238573)

  • 21. LSD acts synergistically with serotonin depletion: evidence from behavioral studies in cats.
    Trulson ME; Jacobs BL
    Pharmacol Biochem Behav; 1976 Mar; 4(3):231-4. PubMed ID: 132670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of lysergic acid diethylamide, methysergide, and cyproheptadine on modality-specific and nonspecific sensory evoked potentials.
    Wilkison DM; Hosko MJ
    Exp Neurol; 1983 Nov; 82(2):391-403. PubMed ID: 6628626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LSD and other related hallucinogens elicit myoclonic jumping behavior in the guinea pig.
    Carvey P; Nausieda P; Weertz R; Klawans H
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):199-210. PubMed ID: 2748860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonism of a behavioral effect of LSD and lisuride in the cat.
    White FJ; Holohean AM; Appel JB
    Psychopharmacology (Berl); 1983; 80(1):83-4. PubMed ID: 6408677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerance to LSD and DOB induced shaking behaviour: differential adaptations of frontocortical 5-HT(2A) and glutamate receptor binding sites.
    Buchborn T; Schröder H; Dieterich DC; Grecksch G; Höllt V
    Behav Brain Res; 2015 Mar; 281():62-8. PubMed ID: 25513973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).
    Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Dowling G; Wallach J; Halberstadt AL
    Drug Test Anal; 2019 Aug; 11(8):1122-1133. PubMed ID: 31083768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the stimulus effects of morphine and lysergic acid diethylamide (LSD).
    Hirschhorn ID; Rosecrans JA
    Pharmacol Biochem Behav; 1974 May; 2(3):361-6. PubMed ID: 4837907
    [No Abstract]   [Full Text] [Related]  

  • 28. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
    Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of LSD and some analogues on the responses of single cortical neurons of the cat to optical stimulation.
    Dray A; Fox PC; Hilmy M; Somjen GG
    Brain Res; 1980 Oct; 200(1):105-21. PubMed ID: 6106524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysergic acid diethylamide (LSD 25). 36. Comparison of effect of methysergide (UML 491) on goldfish and Siamese fighting fish.
    Gettner HH; Rolo A; Abramson HA
    J Psychol; 1965 Sep; 61(1):87-92. PubMed ID: 5834759
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement.
    Halberstadt AL; Geyer MA
    Psychopharmacology (Berl); 2013 Jun; 227(4):727-39. PubMed ID: 23407781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Following several days of continuous administration d-amphetamine acquires hallucinogenlike properties.
    Nielsen EB; Lee TH; Ellison G
    Psychopharmacology (Berl); 1980; 68(2):197-200. PubMed ID: 6776566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions.
    White FJ; Appel JB
    Science; 1982 Apr; 216(4545):535-7. PubMed ID: 7071600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological studies on para-bromo-methamphetamine (V-111) and LSD.
    Knoll J; Vizi ES; Knoll B
    Acta Physiol Acad Sci Hung; 1970; 37(1):151-70. PubMed ID: 5433553
    [No Abstract]   [Full Text] [Related]  

  • 35. The stimulus properties of LSD in C57BL/6 mice.
    Winter JC; Kieres AK; Zimmerman MD; Reissig CJ; Eckler JR; Ullrich T; Rice KC; Rabin RA; Richards JB
    Pharmacol Biochem Behav; 2005 Aug; 81(4):830-7. PubMed ID: 16005500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle.
    Geyer MA; Petersen LR; Rose GJ; Horwitt DD; Light RK; Adams LM; Zook JA; Hawkins RL; Mandell AJ
    J Pharmacol Exp Ther; 1978 Dec; 207(3):837-47. PubMed ID: 731434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [LSD-25 and UML decrease the levels of 5-hydroxyindoleacetic acid in the brain of rat].
    Torre M; Bogetto F; Torre E
    Boll Soc Ital Biol Sper; 1976 Nov; 52(21):1835-7. PubMed ID: 1026256
    [No Abstract]   [Full Text] [Related]  

  • 38. [Inhibiting effect of methysergide bimaleate on the action of LSD-25 on the conditioned reflex of avoidance in the rat].
    Torre M
    Boll Soc Ital Biol Sper; 1972 Jan; 48(1):1-3. PubMed ID: 5031626
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hallucinogen caused motility disorders in rats as potential psychosis relevant animal model].
    Oelssner W
    Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():53-60. PubMed ID: 7157125
    [No Abstract]   [Full Text] [Related]  

  • 40. d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.
    De Gregorio D; Comai S; Posa L; Gobbi G
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.